Cargando…

Trial participation as avoidance strategy: a qualitative study

BACKGROUND: Trial participation decisions are often influenced by expectations of potential benefit. Attention has focused on trial participation as a means of securing something seen as desirable, such as experimental treatment. In contrast, we consider a case in which one trial arm involved receiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Armstrong, Natalie, Shaw, Elizabeth, McColl, Elaine, Tincello, Douglas G., Hilton, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139059/
https://www.ncbi.nlm.nih.gov/pubmed/26730890
http://dx.doi.org/10.1111/hex.12437
_version_ 1782472175954952192
author Armstrong, Natalie
Shaw, Elizabeth
McColl, Elaine
Tincello, Douglas G.
Hilton, Paul
author_facet Armstrong, Natalie
Shaw, Elizabeth
McColl, Elaine
Tincello, Douglas G.
Hilton, Paul
author_sort Armstrong, Natalie
collection PubMed
description BACKGROUND: Trial participation decisions are often influenced by expectations of potential benefit. Attention has focused on trial participation as a means of securing something seen as desirable, such as experimental treatment. In contrast, we consider a case in which one trial arm involved receiving less than usual care. We explore how this influenced participants’ decisions to participate. METHODS: Semi‐structured interviews with 29 women participating in a pilot trial comparing invasive urodynamic testing (typically normal care) to basic clinical assessment with non‐invasive tests, prior to surgical treatment for stress urinary incontinence. Analysis was based on the constant comparative method. RESULTS: Invasive tests were something many were aware of and worried about. Participants understood that trial participation meant they might avoid having these tests, and for about one‐third, this was the primary factor motivating participation. A further third mentioned they were not looking forward to tests (if allocated to them) or were lucky to have missed them (if allocated to basic clinical assessment). None of the women appeared to have discussed their desire to avoid having invasive tests with their clinicians. CONCLUSIONS: In contrast to cases in which trial participation is motivated by the wish to secure an intervention not otherwise available, this study reports the opposite – trial participation as an opportunity to avoid having something regarded as undesirable. The option to decline a particular intervention should always be available, and care must be taken to ensure that potential participants are aware that trial participation is not the only possible means of avoidance.
format Online
Article
Text
id pubmed-5139059
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-51390592016-12-12 Trial participation as avoidance strategy: a qualitative study Armstrong, Natalie Shaw, Elizabeth McColl, Elaine Tincello, Douglas G. Hilton, Paul Health Expect Original Research Papers BACKGROUND: Trial participation decisions are often influenced by expectations of potential benefit. Attention has focused on trial participation as a means of securing something seen as desirable, such as experimental treatment. In contrast, we consider a case in which one trial arm involved receiving less than usual care. We explore how this influenced participants’ decisions to participate. METHODS: Semi‐structured interviews with 29 women participating in a pilot trial comparing invasive urodynamic testing (typically normal care) to basic clinical assessment with non‐invasive tests, prior to surgical treatment for stress urinary incontinence. Analysis was based on the constant comparative method. RESULTS: Invasive tests were something many were aware of and worried about. Participants understood that trial participation meant they might avoid having these tests, and for about one‐third, this was the primary factor motivating participation. A further third mentioned they were not looking forward to tests (if allocated to them) or were lucky to have missed them (if allocated to basic clinical assessment). None of the women appeared to have discussed their desire to avoid having invasive tests with their clinicians. CONCLUSIONS: In contrast to cases in which trial participation is motivated by the wish to secure an intervention not otherwise available, this study reports the opposite – trial participation as an opportunity to avoid having something regarded as undesirable. The option to decline a particular intervention should always be available, and care must be taken to ensure that potential participants are aware that trial participation is not the only possible means of avoidance. John Wiley and Sons Inc. 2016-01-05 2016-12 /pmc/articles/PMC5139059/ /pubmed/26730890 http://dx.doi.org/10.1111/hex.12437 Text en © 2016 The Authors Health Expectations Published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Papers
Armstrong, Natalie
Shaw, Elizabeth
McColl, Elaine
Tincello, Douglas G.
Hilton, Paul
Trial participation as avoidance strategy: a qualitative study
title Trial participation as avoidance strategy: a qualitative study
title_full Trial participation as avoidance strategy: a qualitative study
title_fullStr Trial participation as avoidance strategy: a qualitative study
title_full_unstemmed Trial participation as avoidance strategy: a qualitative study
title_short Trial participation as avoidance strategy: a qualitative study
title_sort trial participation as avoidance strategy: a qualitative study
topic Original Research Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5139059/
https://www.ncbi.nlm.nih.gov/pubmed/26730890
http://dx.doi.org/10.1111/hex.12437
work_keys_str_mv AT armstrongnatalie trialparticipationasavoidancestrategyaqualitativestudy
AT shawelizabeth trialparticipationasavoidancestrategyaqualitativestudy
AT mccollelaine trialparticipationasavoidancestrategyaqualitativestudy
AT tincellodouglasg trialparticipationasavoidancestrategyaqualitativestudy
AT hiltonpaul trialparticipationasavoidancestrategyaqualitativestudy